Nephrocare Health Services IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Wed Dec 10 2025
The Nephrocare Health Services IPO GMP is ₹0 as of 10th December 2025. It is a bookbuilding IPO of ₹871.05 crores. This is an entirely fresh issue of 0.77 crore shares, and an offer for sale of 1.13 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 17th December 2025. The face value of Nephrocare Health Services IPO shares is ₹2 per share, and the IPO price band is ₹438 to ₹460 per share. Retail investors can bid for a minimum of 1 lot of 32 shares worth ₹14,720.
Nephrocare Health Services IPO GMP Grey Market Premium
As mentioned earlier, the Nephrocare Health Services IPO GMP currently stands at ₹0 per share. Thus, the estimated listing price would be flat at ₹460. This indicates that the estimated listing gain in this IPO could be 0.00%. Explore the table for Riddhi Display Equipment IPO GMP updates.
| GMP DATE | IPO Price | GMP Price | Estimated Listing Price | Estimated Gain |
| 10-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
| 9-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
| 8-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
| 7-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
| 6-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
| 5-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
| 4-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
| 3-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
| 2-12-2025 | ₹460.00 | ₹0.00 | ₹460.00 | 0.00% |
Note: GMP details are subject to change based on market conditions and fluctuations. Check the live Nephrocare Health Services IPO GMP status at Univest.
Nephrocare Health Services IPO Details
| IPO Allotment Date | 15th December 2025 |
| IPO Open Date | 10th December 2025 |
| IPO Close Date | 12th December 2025 |
| Refund Initiation | 16th December 2025 |
| Issue Size | 1,89,35,819 shares(aggregating up to ₹871.05 Cr) |
| Fresh Issue | 76,82,717 shares(aggregating up to ₹353.40 Cr) |
| Offer for Sale | 1,12,53,102 shares of ₹2(aggregating up to ₹517.64 Cr) |
| Face Value | ₹2 per share |
| Lot Size | 32 Shares |
| Issue Price | ₹438 to ₹460 per share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE NSE |
| Listing Date | 17th December 2025 |
Also Read: Nephrocare Health Services IPO GMP & Review: Apply or Avoid?
Explanation
Nephrocare Health Services IPO: Nephrocare Health Services IPO Limited has declared an issue price band of ₹438 to ₹460 per share. With this IPO, the company allows retail investors to bid for at least one lot of 32 shares, each worth ₹14,720. The face value of Nephrocare Health Services IPO Limited shares is ₹2 per share. The shares of Nephrocare Health Services IPO Limited will be listed on BSE and NSE on its tentative listing day, 17th December 2025. Scroll down to check GMP updates and Nephrocare Health Services IPO reviews.
Nephrocare Health Services IPO Objectives
The primary aim of the Nephrocare Health Services IPO is to raise ₹871.05 crores. On the other hand, Nephrocare Health Services has decided to utilise these funds in different ways.
- To Capital expenditure by the Company for opening new dialysis clinics in India
- To Pre-payment, or scheduled repayment, in whole or part, of certain borrowings availed by the Company
- For general corporate purposes
Nephrocare Health Services IPO Registrar
Kfin Technologies Limited is the registrar for the Nephrocare Health Services IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Nephrocare Health Services allotment and refund, you can contact Kfin Technologies Limited at parkmedi.ipo@kfintech.com or at 0406716222 or 04079611000.
Nephrocare Health Services IPO Review
The Nephrocare Health Services IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Nephrocare Health Services Limited’s revenue increased by 34% from ₹574.72 crores in March 2024 to ₹769.92 crores in March 2025. Moreover, the company’s PAT increased by 91% from ₹35.13 crores in March 2024 to ₹67.10 crores in March 2025.
Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Nephrocare Health Services IPO or not.
Nephrocare Health Services IPO Technicals
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 63.52 |
| EPS (Earnings Per Share) | 7.24 |
| RoNW | 13.19% |
| ROCE | 18.67% |
| ROE | 13.45% |
| EBITDA Margin | 22.05% |
| Price to Book Value | 7.72 |
| Market Capitalisation | ₹4,615.34 Cr |
The PE ratio of Nephrocare Health Services Limited shares is 63.52, and its Earnings Per Share (EPS) stands at 7.24. Thus, the Nephrocare Health Services IPO can deliver gains on its tentative listing date, 17th December 2025.
Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Nephrocare Health Services Limited are subject to change after the IPO. Explore the table below to get post-issue updates on these two metrics.
| Indicators | Pre-IPO | Post-IPO |
| PE Ratio | 63.52 | 162.19 |
| EPS | 7.24 | 2.84 |
FAQs on Nephrocare Health Services IPO
What is the Nephrocare Health Services IPO GMP?
Currently, on 10th December 2025, the Nephrocare Health Services IPO GMP (Grey Market Premium) stands at ₹0. This indicates that the estimated listing price could be ₹460 per share.
What is the issue price of Nephrocare Health Services IPO?
The Nephrocare Health Services IPO issue price band is set at ₹438.00 to ₹460.00 per share. Retail investors can apply for a minimum of 1 lot, each consisting of 32 shares, worth ₹14,720. Moreover, HNIs are required to bid for a minimum of 14 lots (448 shares) worth ₹2,06,080.
Who is the registrar of the Nephrocare Health Services IPO?
Kfin Technologies Limited is the registrar for the Nephrocare Health Services IPO, awaiting the allotment process and initiating refunds. For any queries regarding the Nephrocare Health Services allotment and refund, you can contact Kfin Technologies Limited at parkmedi.ipo@kfintech.com or 04067162222, 04079611000.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Nephrocare Health Services IPO, download the Nephrocare Health Services IPO RHP and Nephrocare Health Services IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Recent Articles
Ravelcare IPO GMP: Day 3 IPO Live Updates
Astron Multigrain IPO Subscription Day 2
Astron Multigrain IPO GMP: Day 2 IPO Live Updates
Invicta Diagnostic IPO Subscription Day 2
Invicta Diagnostic IPO GMP: Day 2 IPO Live Updates
Nephrocare Health Services IPO GMP & Review: Apply or Avoid?
